Neurology and cognitive disorders
Research activity includes medicines associated with Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders, with attention to treatments used in dementia and cognitive impairment.
- Memantine
- Donepezil
- Rasagiline
The portfolio also reflects interest in central nervous system therapies used in chronic neurological care.
Mental health and psychiatric treatment
Clinical research covers antidepressant therapies and medicines used for mood disorders, with focus on agents relevant to depression management.
- Vortioxetine
- Escitalopram
These studies sit within a broader interest in psychiatric pharmacotherapy and oral formulations for long-term use.
Cardiometabolic and vascular disease
The sponsor funds research on medicines linked to hypercholesterolaemia, diabetes, and prevention of cardiovascular disease, including therapies relevant to thrombotic risk and lipid control.
- Rosuvastatin
- Atorvastatin
- Dapagliflozin
- Linagliptin
- Metformin
- Apixaban
- Edoxaban
Active work in this area spans antidiabetic, lipid-lowering, and anticoagulant treatment domains.
Respiratory and allergic disease
Trials also address asthma and related airway conditions, with interest in medicines used for allergic inflammation and bronchial control.
- Montelukast
This area reflects therapeutic work in respiratory medicine and chronic symptom management.
Healthy volunteer and bioequivalence studies
Much of the research landscape is centred on bioequivalence evaluation of oral formulations in healthy volunteers, supporting development across multiple therapeutic classes.
- Oral capsule and tablet formulations
- Film-coated tablets
- Cross-over formulation comparisons
These studies include medicines intended for neurology, cardiometabolic disease, psychiatry, and respiratory care.
